LEADER 01213nam0-2200349 --450 001 9910349859303321 005 20191129100436.0 010 $a9781455746927 010 $a9996097102 010 $a9996097161 (v. 2 : alk. paper) 035 $a(DNLM)101631364 100 $a20191128d2016----kmuy0itay5050 ba 101 0 $aeng 200 1 $aSleisenger and Fordtran's gastrointestinal and liver disease$epathophysiology diagnosis management$fMark Feldman, Lawrence S. Friedman, Lawrence J. Brandt 205 $a10th ed. 210 1$aPhiladelphia, PA$cSaunders Elsevier$d[2016] 215 $a2 v. (xxxi, 2369, 89 pages)$d29 cm 517 1 $aGastrointestinal and liver disease 610 0 $aGastrointestinal Diseases 610 0 $aLiver Diseases 676 $a616.3/3 702 1$aFeldman,$bMark$f<1947- > 702 1$aFriedman,$bLawrence S.$g(Lawrence Samuel),$f<1953- > 702 1$aBrandt,$bLawrence J. 801 0$aIT$bUNINA$gREICAT$2UNIMARC 901 $aBK 912 $a9910349859303321 952 $a90 R 4a 37 I$b285/2019$fFMEBC 952 $a90 R 4a 37 II$b286/2019$fFMEBC 959 $aFMEBC 996 $aSleisenger and Fordtran's gastrointestinal and liver disease$91566561 997 $aUNINA